Kalyana Srujana

Papers

Total Citations

H-Index

About

Kalyana Srujana is a clinical researcher whose work centers on optimizing perioperative care in urologic oncology, with a particular focus on enhanced recovery after surgery (ERAS) protocols. Her most cited study, "Alvimopan as an essential component of ERAS protocol to decrease length of hospital stay," examines how the addition of Alvimopan—a peripherally acting mu-opioid receptor antagonist—can accelerate gastrointestinal recovery and reduce hospital stays for patients undergoing radical cystectomy for muscle invasive bladder cancer. This work contributes to a growing body of evidence supporting multimodal, evidence-based pathways that improve patient outcomes and reduce healthcare costs. Though early in her citation impact, Srujana’s research addresses a critical challenge in major pelvic surgery: balancing effective pain management with faster recovery. Her findings highlight the practical integration of pharmacologic and non-pharmacologic ERAS elements, offering a template for surgical teams aiming to shorten length of stay without compromising care quality. For students and clinicians interested in perioperative innovation, Srujana’s work underscores how targeted interventions can transform recovery trajectories in high-risk surgical populations.